Braxia Scientific Statistics
Braxia Scientific (BRAX) Stock Statistics & Valuation Metrics
Total Valuation
Braxia Scientific has a market cap or net worth of CAD 1.42M. The enterprise value is CAD 3.04M.
- Market Cap
- CAD 1.42M
- Enterprise Value
- CAD 3.04M
Share Statistics
Braxia Scientific has 283,280,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 283,280,360
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Braxia Scientific’s return on equity (ROE) is -8.19 and return on invested capital (ROIC) is -408.30%.
- Return on Equity (ROE)
- -8.19
- Return on Assets (ROA)
- -3.38
- Return on Invested Capital (ROIC)
- -408.30%
- Return on Capital Employed (ROCE)
- -4.31
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.49
- Inventory Turnover
- 197.35
Valuation Ratios
The current PE Ratio of Braxia Scientific is -0.09. Braxia Scientific’s PEG ratio is -0.00.
- PE Ratio
- -0.09
- PS Ratio
- 0.75
- PB Ratio
- 0.71
- Price to FCF
- -0.17
- Price to Operating Cash Flow
- -0.15
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Braxia Scientific had revenue of 1.88M and earned -13.14M in profits. Earnings per share was -0.06.
- Revenue
- 1.88M
- Gross Profit
- 171.74K
- Operating Income
- -7.48M
- Pretax Income
- -13.29M
- Net Income
- -13.14M
- EBITDA
- -12.72M
- Earnings Per Share (EPS)
- -0.06
Cash Flow
In the last 12 months, operating cash flow was -2.58M and capital expenditures -42,646, giving a free cash flow of -2.63M billion.
- Operating Cash Flow
- -2.58M
- Free Cash Flow
- -2.63M
- Free Cash Flow per Share
- -0.04
Dividends & Yields
Braxia Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -586.11%
- Earnings Yield
- -1150.66%
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- 13.30K
Important Dates
Braxia Scientific upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Nov 26, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Braxia Scientific as a current ratio of 1.00, with Debt / Equity ratio of 12.91%
- Current Ratio
- 1.00
- Quick Ratio
- 1.00
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.10
- Interest Coverage Ratio
- -419.27
Taxes
In the past 12 months, Braxia Scientific has paid -145.88K in taxes.
- Income Tax
- -145.88K
- Effective Tax Rate
- 0.01
Enterprise Valuation
Braxia Scientific EV to EBITDA ratio is -0.01, with an EV/FCF ratio of -0.02.
- EV to Sales
- 0.09
- EV to EBITDA
- -0.01
- EV to Free Cash Flow
- -0.02
- EV to Operating Cash Flow
- -0.02
Balance Sheet
Braxia Scientific has CAD 128.34K in cash and marketable securities with CAD 636.63K in debt, giving a net cash position of -CAD 508.29K billion.
- Cash & Marketable Securities
- CAD 128.34K
- Total Debt
- CAD 636.63K
- Net Cash
- -CAD 508.29K
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- CAD 0.01
Margins
Gross margin is 9.12%, with operating margin of -397.00%, and net profit margin of -697.48%.
- Gross Margin
- 9.12%
- Operating Margin
- -397.00%
- Pretax Margin
- -705.22%
- Net Profit Margin
- -697.48%
- EBITDA Margin
- -675.17%
- EBIT Margin
- -704.27%
Analyst Forecast
The average price target for Braxia Scientific is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
